Schrödinger to Present at SVB Securities Global Biopharma Conference

Rhea-AI Summary

Schrödinger (Nasdaq: SDGR) will participate in the SVB Securities Global Biopharma Conference on February 14, 2023, at 1:00 p.m. ET. The presentation details will be available under the "News & Events" section on their website and archived for seven days. Schrödinger is known for its innovative physics-based computational platform that accelerates the discovery of novel molecules for drug and material development. Founded in 1990, the company has over 800 employees and partners globally in over 70 countries.

NEW YORK--(BUSINESS WIRE)-- Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in the SVB Securities Global Biopharma Conference and will give a presentation on Tuesday, February 14, 2023, at 1:00 p.m. ET.

The live discussion can be accessed under "News & Events" in the investors section of Schrödinger’s website, https://ir.schrodinger.com/news-and-events/event-calendar and will be archived for approximately seven days.

About Schrödinger
Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based computational platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is licensed by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages the software platform to advance a portfolio of collaborative and proprietary programs to address unmet medical needs.

Founded in 1990, Schrödinger has over 800 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com, follow us on LinkedIn and Instagram, or visit our blog, Extrapolations.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230131005020/en/

Jaren Irene Madden (Investors)

Schrödinger, Inc.

jaren.madden@schrodinger.com

617-286-6264

Tracy Lessor (Media)

Schrödinger, Inc.

tracy.lessor@schrodinger.com

617-519-9827

Source: Schrödinger

FAQ

What is the date and time of Schrödinger's presentation at the SVB Securities Global Biopharma Conference?

Schrödinger's presentation is scheduled for February 14, 2023, at 1:00 p.m. ET.

How can I access the presentation by Schrödinger at the conference?

You can access the presentation through the "News & Events" section on Schrödinger's website.

What innovative platform does Schrödinger use for drug discovery?

Schrödinger employs a physics-based computational platform for accelerating the discovery of novel molecules.

How long will the conference presentation be available for viewing?

The presentation will be archived for approximately seven days after the event.

What is the stock symbol of Schrödinger?

The stock symbol for Schrödinger is SDGR.